C
PTCT icon

Covestor’s PTC Therapeutics PTCT Stock Holding History

Covestor’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152K Buy
1,857
+576
+45% +$41.6K 0.09% 192
2026
Q1 		$87K Sell
1,281
-1,174
-48% -$83.1K 0.06% 358
2025
Q4 		$187K Sell
2,455
-1,891
-44% -$137K 0.1% 249
2025
Q3 		$267K Buy
4,346
+4,121
+1,832% +$215K 0.15% 112
2025
Q2 		$11K Buy
225
+221
+5,525% +$10.5K 0.01% 1552
2025
Q1 		$0 Hold
4
– – ﹤0.01% 2621
2024
Q4 		$0 Sell
4
-1
-20% -$43 ﹤0.01% 2630
2024
Q3 		$0 Hold
5
– – ﹤0.01% 2642
2024
Q2 		$0 Hold
5
– – ﹤0.01% 2644
2024
Q1 		$0 Sell
5
-1
-17% -$28 ﹤0.01% 2630
2023
Q4 		$0 Buy
6
+2
+50% +$46 ﹤0.01% 2589
2023
Q3 		$0 Sell
4
-1
-20% -$37 ﹤0.01% 2584
2023
Q2 		$0 Sell
5
-188
-97% -$9.2K ﹤0.01% 2533
2023
Q1 		$9K Buy
193
+188
+3,760% +$8.59K 0.01% 1376
2022
Q4 		$0 Hold
5
– – ﹤0.01% 2485
2022
Q3 		$0 Sell
5
-1
-17% -$49 ﹤0.01% 2455
2022
Q2 		$0 Sell
6
-4
-40% -$140 ﹤0.01% 2264
2022
Q1 		$0 Sell
10
-3
-23% -$116 ﹤0.01% 2371
2021
Q4 		$1K Buy
+13
New +$498 ﹤0.01% 1894

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Covestor's PTCT Position: Q2 2026 in Review

Covestor increased its PTC Therapeutics (PTCT) stake by 45% in Q2 2026, buying an estimated $41.6K and bringing the position to 1,857 shares worth $152K. The position accounts for 0.09% of the portfolio, ranked #192.

Covestor first reported a position in PTCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $267K in Q3 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Covestor held 1,857 shares of PTC Therapeutics worth $152K as of Q2 2026.
  • Covestor bought 576 PTC Therapeutics shares in Q2 2026, an estimated $41.6K.
  • PTC Therapeutics made up 0.09% of Covestor's portfolio in Q2 2026, its #192 holding.
  • Covestor first reported a position in PTC Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Covestor's PTC Therapeutics position peaked at $267K in Q3 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.